Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line

The use of NK cells in adoptive therapy for malignant disease is an area of great potential. Currently the only NK cell line in clinical trials is NK-92, an activated NK cell line with a broad range of cytotoxicity against malignant cells. The activity of NK-92 against pre-B acute lymphoblastic leuk...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: REID, G S D, BHARYA, S, KLINGEMANN, H-G, SCHULTZ, K R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2002
Konular:
Basic Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1906454/
https://ncbi.nlm.nih.gov/pubmed/12165082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.2002.01919.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller